The Emphysema Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The emphysema market has seen robust growth recently. The market size is forecasted to increase from $4.74 billion in 2024 to $4.99 billion in 2025, representing a compound annual growth rate (CAGR) of 5.2%.
By 2029, the emphysema market is projected to reach a size of $6.05 billion, growing at a compound annual growth rate (CAGR) of 4.9%.
Download Your Free Sample of the 2025 Emphysema Market Report and Uncover Key Trends Now!The key drivers in the emphysema market are:
• Increase in healthcare spending
• Rise in environmental pollution
• Growing demand for diagnostic medical devices
• Increased popularity of minimally invasive procedures
The emphysema market covered in this report is segmented –
1) By Type: Centrilobular, Panlobular
2) By Treatment: Medication, Therapy, Surgery, Other Treatments
3) By Diagnosis: Imaging Test, Lung Function Test, Other Diagnosis
4) By Complications: Chest Infections, Collapsed Lung, Heart Problems, Lungs Hole, Other Complications
5) By End-user: Hospitals And Clinics, Surgical Center, Other End-users
Subsegments:
1) By Centrilobular: Mild Centrilobular Emphysema, Moderate Centrilobular Emphysema, Severe Centrilobular Emphysema
2) By Panlobular: Mild Panlobular Emphysema, Moderate Panlobular Emphysema, Severe Panlobular Emphysema
The key trends in the emphysema market are:
• The development and application of new inhalation devices are notable future trends.
• Strategic alliances and partnerships in the industry are increasingly influencing the market.
• Personalized medicine emerges as a significant trend for the future of emphysema treatment.
• The utilization of telemedicine and advancements in inhalation therapies are shaping the industry.
Major players in the emphysema market are:
• Pfizer Inc.
• Merck & Co. Inc.
• Sanofi S.A.
• AstraZeneca PLC
• Novartis International AG
• GlaxoSmithKline PLC
• Takeda Pharmaceutical Company Limited
• Koninklijke Philips N.V.
• Teva Pharmaceutical Industries Ltd.
• Boehringer Ingelheim
• Mylan N.V.
• Olympus Corporation
• ResMed Inc.
• Chiesi Farmaceutici S.p.A.
• University of Chicago Medicine (UChicago Medicine)
• Hikma Pharmaceuticals PLC
• United Therapeutics Corporation
• VIDA Diagnostics Inc.
• Kamada Limited
• Pulmonx Corporation
• Mereo BioPharma Group PLC
• Uptake Medical Corporation
• Verona Pharma PLC.
North America was the largest region in the emphysema market in 2024